UK drug update - January 2005

Published: 7-Jan-2005
Regulatory


Servier Laboratories has brought out Protelos, 2g sachets of the bone disease treatment strontium ranelate.

Pfizer has launched Inspra tablets, containing 25 or 50mg of the aldosterone antagonist eplerenone.

Ivax has made available Qvar Easi-Breathe in 50µg and 100µg per dose presentations, containing the cortico-steroid beclometasone dipropionate.

AstraZeneca has launched Zomig Rapimelt containing 5mg tablets of the 5-hydroxytryptamine-1 agonist zolmitriptan.

Novartis has introduced Diovan tablets containing 40mg of the angiotensin II antagonist valsartan.

Alpharma has added 200µg, 300µg and 400µg tablets of the imidazoline-1 agonist moxonidine, and 1.25mg, 2.5mg, 5mg and 10mg tablets of the ACE inhibitor ramipril to its product range.

Sandoz has brought out 50µg, 250µg and 1mg tablets of the dopamine agonist pergolide.

UCB Pharma has marketed Keppra containing the pyrrolidone derivative levetiracetam as a 100mg/mL oral solution and 750mg film-coated tablets.

APS/Berk has launched 200µg, 300µg and 400µg tablets of the imidazoline-1 agonist moxonidine.

Almus has introduced 50µg and 100µg tablets of the thyroid hormone thyroxine; 25mg, 50mg and 100mg tablets of the potassium-sparing diuretic spironolactone and 500µg tablets of the nitrate glyceryl trinitrate.

Eli Lilly & Co has launched Alimta, a specialised hospital-only product containing 500mg/vial of the folic acid analogue pemetrexed (as pemetrexed disodium).

Nycomed UK has made available Angiox. The product, available as 250mg vials, contains the antithrombotic agent bivalirudin.

Genus Pharmaceuticals has introduced the cephalosporin ceftazidime as 500mg, 1g and 2g powder for injection vials. The company has also launched 200µg, 300µg and 400µg tablets of the imidazoline-1 agonist moxonidine.

See more

You may also like

Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

Read more
New SOLAR CEMNEX analyser offers advanced compliance and connectivity features

Trending Articles

  1. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste
  2. Balancing innovation and accessibility in amino acid testing Butterworth Laboratories expands analytical capabilities to support compliance with Ph. Eur. standards
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Quality management during manufacturing changes: part I Change is a universal constant and continues to accelerate in the realms of pharmaceutical, medical device and in-vitro diagnostic manufacturers who face ever-increasing pressure to optimise costs while maintaining high product quality and patient safety standards
  4. NICE recommends enfortumab vedotin with KEYTRUDA for adults in England/Wales with untreated metastatic urothelial cancer The results from the Phase III study EV-302/KN-A39 showed nearly a doubling of survival rates in patients compared with those who received platinum-based chemotherapy, which is the current standard of care in the UK
  5. FDA makes groundbreaking decision to waive clinical efficiency studies for monoclonal antibody biosimilars The University of Illinois secured the first-ever FDA acceptance to waive clinical efficiency studies (CESs) for the biological drugs

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Cloud labelling and serialisation: the new frontline of traceability in drug delivery

As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
Regulatory

Novo Nordisk’s oral semaglutide scores EU approval for cardiovascular benefits

Rybelsus is now the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
Manufacturing

Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision

Partnership delivers compliance confidence, efficiency gains and reduced waste
Regulatory

New NICE thresholds: good news for rare disease drugs but process remains complex

Recent changes introduced by NICE will ultimately see more ultra-rare disease drugs get to market, but Dan Williams, CEO at SynaptixBio, says the process remains challenging
Manufacturing

Balancing innovation and accessibility in amino acid testing

Butterworth Laboratories expands analytical capabilities to support compliance with Ph. Eur. standards
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Quality management during manufacturing changes: part I

Change is a universal constant and continues to accelerate in the realms of pharmaceutical, medical device and in-vitro diagnostic manufacturers who face ever-increasing pressure to optimise costs while maintaining high product quality and patient safety standards
Subscribe now